-
-
-
-
-
-
-
Lisata Therapeutics regains China rights to certepetide drug
-
-
-
-
-
-
-
Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Lisata Therapeutics Announces Enhancements to Ongoing Phase 2b ASCEND Trial of LSTA1
-
-
-
-
-
-
-
Lisata Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
1,178,426 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

